CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS

Authors

  • Faizullaeva N. Ya. Author
  • Mukhtorov Sh. M. Author
  • Raufov A. A. Institute of Human Immunology and Genomics of the Academy of Sciences of the Republic of Uzbekistan Author

Keywords:

Bronchial asthma, type 2 diabetes mellitus, cytokines, endothelin-1, glycated hemoglobin, comorbidity, immunobiochemical markers.

Abstract

The relevance of the study is due to the high frequency of bronchial asthma (BA) and type 2 diabetes mellitus (T2DM), which mutually aggravate each other. The aim of the study was to investigate clinical and immunobiochemical markers to optimize the diagnosis and assess the severity of BA combined with T2DM.

Downloads

Published

2025-11-13

Issue

Vol. 1 No. 8 (2025)

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

CLINICAL IMMUNOBIOCHEMICAL MARKERS IN OPTIMIZING THE DIAGNOSTICS OF BRONCHIAL ASTHMA IN COMORBIDITY WITH TYPE 2 DIABETES MELLITUS. (2025). Modern American Journal of Medical and Health Sciences, 1(8), 51-63. https://usajournals.org/index.php/1/article/view/1362